On August 22, 2025, the Genetico Board of Directors appointed Igor Zharkikh as the company's new General Director. Genetico's new General Director will assume his position on September 2, 2025.
Vladimir Kaymanov, who has served as Genetico's General Director since 2021, will remain in the company's Board of Directors.
Igor Zharkikh has extensive management experience in both international and Russian companies. He has previously served as General Director of Sagmel pharmaceutical company, Orteka orthopedic salon chain, and Lechu.ru medical center chain. He has also held various positions at Russian healthcare companies, including ABC-Medicine medical center chain and Sber's Health Industry Center.
Genetico Center (CGRM, MOEX: GECO) is a resident of Skolkovo and the Medtech Technopark and is part of Artgen Biotech Group (MOEX: ABIO). The company specializes in medical genetics and genetic research, implementing innovative solutions for the diagnostics, prevention, and treatment of genetic and socially significant diseases in healthcare practice.